These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 19470219)

  • 1. Identifying new cannabis use with urine creatinine-normalized THCCOOH concentrations and time intervals between specimen collections.
    Smith ML; Barnes AJ; Huestis MA
    J Anal Toxicol; 2009 May; 33(4):185-9. PubMed ID: 19470219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiating new cannabis use from residual urinary cannabinoid excretion in chronic, daily cannabis users.
    Schwilke EW; Gullberg RG; Darwin WD; Chiang CN; Cadet JL; Gorelick DA; Pope HG; Huestis MA
    Addiction; 2011 Mar; 106(3):499-506. PubMed ID: 21134021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary excretion profiles of 11-nor-9-carboxy-Delta9-tetrahydrocannabinol: a Delta9-THC-COOH to creatinine ratio study #2.
    Fraser AD; Worth D
    Forensic Sci Int; 2003 Apr; 133(1-2):26-31. PubMed ID: 12742686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary excretion profiles of 11-nor-9-carboxy-Delta9-tetrahydrocannabinol. Study III. A Delta9-THC-COOH to creatinine ratio study.
    Fraser AD; Worth D
    Forensic Sci Int; 2003 Nov; 137(2-3):196-202. PubMed ID: 14609657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary excretion profiles of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in humans after single smoked doses of marijuana.
    Huestis MA; Mitchell JM; Cone EJ
    J Anal Toxicol; 1996 Oct; 20(6):441-52. PubMed ID: 8889681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elimination of 11-nor-9-carboxy-delta-9-tetrahydrocannabinol when normalized to urinary creatinine.
    Beardsley GD; Christensen JM
    Res Commun Mol Pathol Pharmacol; 2007-2008; 120-121(1-6):67-78. PubMed ID: 21469505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic Characterization of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in Urine Following Acute Oral Cannabis Ingestion in Healthy Adults.
    Schlienz NJ; Cone EJ; Herrmann ES; Lembeck NA; Mitchell JM; Bigelow GE; Flegel R; LoDico CP; Hayes ED; Vandrey R
    J Anal Toxicol; 2018 May; 42(4):232-247. PubMed ID: 29300962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary Excretion Profile of 11-Nor-9-Carboxy-Δ9-Tetrahydrocannabinol (THCCOOH) Following Smoked and Vaporized Cannabis Administration in Infrequent Cannabis Users.
    Spindle TR; Cone EJ; Schlienz NJ; Mitchell JM; Bigelow GE; Flegel R; Hayes E; Vandrey R
    J Anal Toxicol; 2020 Jan; 44(1):1-14. PubMed ID: 31095692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended urinary Delta9-tetrahydrocannabinol excretion in chronic cannabis users precludes use as a biomarker of new drug exposure.
    Lowe RH; Abraham TT; Darwin WD; Herning R; Cadet JL; Huestis MA
    Drug Alcohol Depend; 2009 Nov; 105(1-2):24-32. PubMed ID: 19631478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of marijuana use by oral fluid and urine analysis following single-dose administration of smoked and oral marijuana.
    Niedbala RS; Kardos KW; Fritch DF; Kardos S; Fries T; Waga J; Robb J; Cone EJ
    J Anal Toxicol; 2001; 25(5):289-303. PubMed ID: 11499881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary 11-nor-9-carboxy-tetrahydrocannabinol elimination in adolescent and young adult cannabis users during one month of sustained and biochemically-verified abstinence.
    Schuster RM; Potter K; Vandrey R; Hareli M; Gilman J; Schoenfeld D; Evins AE
    J Psychopharmacol; 2020 Feb; 34(2):197-210. PubMed ID: 31535597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid elimination of Carboxy-THC in a cohort of chronic cannabis users.
    Lewis J; Molnar A; Allsop D; Copeland J; Fu S
    Int J Legal Med; 2016 Jan; 130(1):147-52. PubMed ID: 26233612
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary elimination of 11-nor-9-carboxy-delta9-tetrahydrocannnabinol in cannabis users during continuously monitored abstinence.
    Goodwin RS; Darwin WD; Chiang CN; Shih M; Li SH; Huestis MA
    J Anal Toxicol; 2008 Oct; 32(8):562-9. PubMed ID: 19007504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary clearance of 11-nor-9-carboxy-Δ
    Sempio C; Huestis MA; Kaplan B; Klawitter J; Christians U; Henthorn TK
    Drug Test Anal; 2022 Aug; 14(8):1368-1376. PubMed ID: 35332698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cannabinoid concentrations in hair from documented cannabis users.
    Huestis MA; Gustafson RA; Moolchan ET; Barnes A; Bourland JA; Sweeney SA; Hayes EF; Carpenter PM; Smith ML
    Forensic Sci Int; 2007 Jul; 169(2-3):129-36. PubMed ID: 16963215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary cannabinoid disposition in occasional and frequent smokers: is THC-glucuronide in sequential urine samples a marker of recent use in frequent smokers?
    Desrosiers NA; Lee D; Concheiro-Guisan M; Scheidweiler KB; Gorelick DA; Huestis MA
    Clin Chem; 2014 Feb; 60(2):361-72. PubMed ID: 24185550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence.
    Lee D; Milman G; Barnes AJ; Goodwin RS; Hirvonen J; Huestis MA
    Clin Chem; 2011 Aug; 57(8):1127-36. PubMed ID: 21677094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short communication: Urinary excretion of 11-nor-9-carboxy-Delta(9)-tetrahydrocannabinol in a pregnant woman following heavy, chronic cannabis use.
    Westin AA; Huestis MA; Aarstad K; Spigset O
    J Anal Toxicol; 2009; 33(9):610-4. PubMed ID: 20040136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle.
    Niedbala RS; Kardos KW; Fritch DF; Kunsman KP; Blum KA; Newland GA; Waga J; Kurtz L; Bronsgeest M; Cone EJ
    J Anal Toxicol; 2005 Oct; 29(7):607-15. PubMed ID: 16419389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary excretion profiles of 11-nor-9-carboxy-delta9-tetrahydrocannabinol: a delta9-THCCOOH to creatinine ratio study.
    Fraser AD; Worth D
    J Anal Toxicol; 1999 Oct; 23(6):531-4. PubMed ID: 10517562
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.